Objectives: To assess airway, safety, and resource utilization outcomes between transoral base of tongue (BOT) surgery with staged versus concurrent bilateral neck dissections (BND). Methods: A retrospective cohort study of patients with human papilloma virus (HPV)-related BOT cancer who underwent transoral surgery and BND from January 2015 through June 2022 was conducted. Free flap patients were excluded. Results: Of 126 patients (46 [37%] staged and 80 [63%] concurrent BND), there were no significant differences in rates of postoperative intubation, tracheostomy, intensive care admission, operative takebacks, gastrostomy, and 30-day readmission. Total operative time (median difference 1.4 [95% CI 0.9–1.8] hours), length of stay (1.0 [1.0–1.0] day), and time between primary surgery and adjuvant therapy initiation (4.0 [0.0–8.0] days) were lower in the concurrent BND cohort. Conclusion: Concurrent BND alongside transoral BOT resection is safe with similar airway outcomes and lower total operative time, length of stay, and time to adjuvant therapy initiation compared to staged BND.

Original languageEnglish
Pages (from-to)1020-1027
Number of pages8
JournalHead and Neck
Issue number5
StatePublished - May 2024


  • airway
  • base of tongue
  • bilateral
  • cancer
  • concurrent
  • laser
  • neck dissection
  • oropharyngeal
  • robotic
  • squamous cell carcinoma
  • staged
  • transoral


Dive into the research topics of 'Airway protection and outcomes after staged versus concurrent bilateral neck dissections with transoral base of tongue cancer resection'. Together they form a unique fingerprint.

Cite this